Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The reason you do not have PR from TD2 is simple to understand. Technically it is PCMB that has enters into an agreement and has mandated TD2 to perform the preclinical study and any PR about any results / update will come from PMCB unless they give delegation of duties to TD2 to release itself a PR. This is how communication channel works in clinical research. So no point to look for hidden agenda.
Process to get COMP minutes takes few weeks and are not made available until final adoption! so until then EMA will not release these. For the Dec meetings these should be available end Jan / early Feb 2015.
Please read the post below, per my understanding reviewing the application date the COMP would review NVLX in Jan 2015 meeting. if I am wrong Iet us know
Only one single PR to give update EMA & FDA OD to come out when
Good morning all, for review at EMA COMP meeting 9-11Dec 2014, application deadline was 28 August and NVLX made application on 2 Sept, so if I am correct the review would be in the January meeting. Please correct me if I am wrong.
Long NVLX
Kindly appreciated, respect to you and to all who provide relevant information.
This is an article that is essential to read for the new people to understand the quality of people involved directly or indirectly with NVLX clinical development/ research being processed.
One advice I would ask is to be transparent with the reader of the post is to clearly indicate the date the article was published.
If information is new this should be clearly stated and if information provided is a repeat of previous info this should be indicated too.
Long with NVLX
Hi everyone, my understanding is that NVLX was discussed for 2nd round/opinion (which usually leads to a positive opinion being granted) during the EMA meeting on 11-13 Nov 2014.
Keep faith in NVLX
Morning, see paper in British Journal Cancer -Br J Cancer July 10, 2012; 107 (2): 360-369.
Also a book worth reading Macromolecular Anticancer Therapeutics, Humana Press, Springer
Nice and long with NVLX
These kinds of preclinical studies last around 20-22 weeks, we are only entering the week 12.... so patience is needed. This does not mean that the all control mice have survived so far but results cannot be released yet. Patience will be rewarded.
Another great news on NVLX move to success
Thank you, I appreciate the comments and DD you and some have provided recently and keep faith. To be honest from my end, I do not have much insight into any historical facts about CTKH and unfortunately do not know anything either about the story of keegy (what this is about ???). Have a nice day. Thkx.
Penemy, hi, in your post I understood that you would post something of interest. No sure I have seen it. Could you repost please and explain what it would be about. Thanks.
Hello, can you please be more specific about this 13F (sub date, where did you see this info...) and provide to this board, thkx
Hello, selecting a CRO is major step before starting set up phase of clinical trials, since CRO are expert in running the trials. With today news, I am pretty sure that the project management and clinical team is getting ready to get the phase 3 up and running. To keep in mind time to select sites, get sites\countries approval from ethics committee and initiate sites (ie depending on the countries may take at minimum 10 weeks. But already getting the CRO is a very strong sign that the phase 3 will start.
The News to understand is that NVLX has selected of the Clinical Research Organization (CRO) bring them closer to initiating their phase 3 study. This is real news and what people who know about clinical trials look for. Entering set-up phase for starting the phase 3 study. .. Steps to select sites, regulatory submission to IEC/IRB, initiate sites and patients enrollment.
Hi Ramspace, thanks. Will trust this to move up :)
Managed to get 10M @0,0001 two days ago :) After few weeks reading and assessing valuable comments.
Not sure I understand his strategy (100 @ 0001) can someone explain, cheers
Cheeky; Thank you for your reply and the factual information/links you sent me. Based on the info you shared I will certainly invest few euros ( as I am based in France) in CTKH and see how over the next 6 to 12 months these will be moving.
Cheeky ; Thank you for your reply and the factual information/links you sent me. Based on the info you shared I will certainly invest few euros ( as I am based in France) in CTKH and see how over the next 6 to 12 months these will be moving.
Hi, back in Sept last year I was looking with some interest to CTKH and further to sound advice and reading through what was on this board, I did not think it was a time to start buying some CTKH shares. Now I see there is some movement and I would greatly appreciate if this is the opportunity to be part of this. Thank you for your informative advice.
Encourage to listen to yesterday presentation, excellent and very positive looking forward imo.
AF statement about KERX unlikely to receive NCE is misleading.
While Velphoro's is using sucroferric oxyhydroxide, Zerenex is using ferric citrate.
These cannot be compared and certainly one cannot assume as Mr AF appears to do that because Velphoro's did not receive NCE that Zerenex ferric citrate could not receive it.
Why reason for dropping?
120 only traded at 0,0005 is a joke!!!!
No trade today?
Thank you
Hello, Any newsletter from the presentation?
Hi, after reading several posts and what I understand we'll documented messages to this board from you and your friends who seems to know Mr Hilal's company and his management I have decided this time not to "invest" on this pennystock.... At least for the short term but will keep an eye on it. Maybe in few months time I change my mind. Thanks, regards
Thanks:) Will read through the post 18295 as you indicate.
Hello, new to this board and wanting to know if there is value in buying this CTKH; thank you for any advices / comments
Hi, maybe you could read 10-K filing done August 2012; hope this help to reassure
Interesting article on nano particle and diabetes... for those interested posted in American chemical society Nano. Enjoy the reading and understand its potential
http://pubs.acs.org/doi/full/10.1021/nn400630x
Agree; too many info kills the info
Hi everyone, I am new here but over the past few days I notice mainly the same info /messages being posted over and over. This is disconcerting. Should you wish to present information.... and if not new, remember to quote the date when this was first published so there is no misunderstanding.
Please provide the result/ data for this phase II study, would be interesting. Title of the phase II trial, which country (ies) involved, which site(s) , any key opinion leader? thx